Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Aardvark Therapeutics, Inc.

NASDAQ: AARD · Life Sciences · 5 alerts · CIK 1774857

Share price
$1.26Close, Nov 16
Market cap
$27.6M
Shares outstanding
21.89MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Aardvark Therapeutics, Inc. filings on SEC EDGAR ↗

4:17 PM ET 8-K
Business Update

Aardvark Therapeutics Business Update

The FDA has lifted the clinical hold on Aardvark Therapeutics' Investigational New Drug (IND) application for ARD-101, which is being developed to treat hyperphagia in Prader-Willi Syndrome. The hold was originally placed in May 2026 following reversible ECG changes in healthy volunteers, but subsequent studies showed no cardiac events at therapeutic doses. The company plans to resume clinical development following further alignment with the FDA on Phase 3 trial design.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.